CARVER JENNIFER 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Mar 4, 2019
Insider Transaction Report
Form 4
CARVER JENNIFER
Sr. Vice President, Operations
Transactions
- Award
Common Stock
2019-02-28$4.85/sh+230$1,116→ 14,049 total - Award
Stock Option (Right to Buy)
2019-02-28+230→ 230 totalExercise: $5.70Exp: 2029-02-28→ Common Stock (230 underlying)
Footnotes (2)
- [F1]These shares were acquired on 02/28/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.